Floatz logo

Therapeutic Asset Ratings

374 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
[68ga]ga-dwj155
Breast Neoplasm
Novartis PharmaceuticalsP1C (37)
[68ga]ga-dwj155
Non-Small Cell Lung Carcinoma
Novartis PharmaceuticalsP1C (37)
[68ga]ga-evs459
Lung Cancer
Novartis PharmaceuticalsP1C (37)
[68Ga]Ga-NNS309
Pancreatic Ductal Adenocarcinoma
Novartis PharmaceuticalsP1C (37)
[68Ga]Ga-NNS309
Triple-Negative Breast Carcinoma
Novartis PharmaceuticalsP1C (37)
68Ga-NNS309
Triple-Negative Breast Carcinoma
Novartis PharmaceuticalsP1C (37)
dky709
Non-Small Cell Lung Carcinoma
Novartis PharmaceuticalsP1C (37)
dky709
Melanoma
Novartis PharmaceuticalsP1C (37)
dky709
Triple-Negative Breast Carcinoma
Novartis PharmaceuticalsP1C (37)
imj995 single agent
Acute Lymphoblastic Leukemia
Novartis PharmaceuticalsP1C (37)
kfa115
Non-Small Cell Lung Carcinoma
Novartis PharmaceuticalsP1C (37)
otq923
Sickle Cell Disease
Novartis PharmaceuticalsP1C (37)
qeq278
Non-Small Cell Lung Carcinoma
Novartis PharmaceuticalsP1C (37)
Sabatolimab
Myelodysplastic Syndrome
Novartis PharmaceuticalsP1/2C (37)
177lu-dfc413
Colorectal Cancer
Novartis PharmaceuticalsP1C (36)
177lu-dfc413
Non-Small Cell Lung Carcinoma
Novartis PharmaceuticalsP1C (36)
[177lu]lu-evs459
Ovarian Cancer
Novartis PharmaceuticalsP1C (36)
[177lu]lu-nns309
Colorectal Cancer
Novartis PharmaceuticalsP1C (36)
[177lu]lu-nns309
Non-Small Cell Lung Carcinoma
Novartis PharmaceuticalsP1C (36)
225ac-psma-r2
Prostate Cancer
Novartis PharmaceuticalsP1C (36)
[68ga]ga-dwj155
Breast Cancer
Novartis PharmaceuticalsP1C (36)
[68ga]ga-evs459
Ovarian Cancer
Novartis PharmaceuticalsP1C (36)
[68Ga]Ga-NNS309
Colorectal Cancer
Novartis PharmaceuticalsP1C (36)
[68Ga]Ga-NNS309
Non-Small Cell Lung Carcinoma
Novartis PharmaceuticalsP1C (36)
68Ga-NNS309
Colorectal Cancer
Novartis PharmaceuticalsP1C (36)
Showing 326 to 350 of 374 assets
PreviousPage 14 of 15Next